28Feb 2023
Cell‐free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients

Cell‐free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients

The article discusses how cell-free DNA (cfDNA) in blood plasma can be used to identify the epigenetic profile of the cell of origin. The study hypothesizes that cell-free chromatin immunoprecipitation (cfChIP) of H3K36me3-modified nucleosomes present in blood plasma can help determine tumor gene expression levels. The study used H3K36me3 cfChIP followed by targeted NGS (cfChIP-seq) on blood plasma samples from non-small cell lung cancer patients (NSCLC, n=8), small cell lung cancer patients (SCLC, n=4), and healthy controls (n=4). The results showed that H3K36me3 cfChIP-seq can identify mutated alleles and genes differentially expressed in SCLC and NSCLC tumors. The study suggests that this approach can help characterize treatment resistance, cancer subtyping, and disease progression using cfDNA in liquid biopsies.

  • #oncology

Like

Save

Share